Finzati - Logo
TCRT logo

Alaunos Therapeutics, Inc.

TCRT • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$4.59M
Growth
-22.5%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 2.45Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$4.59M
52W Range1.67 - 4.59
Beta-0.96
Gross Margin100.00%
Oper. Margin-845.00%
Profit Margin-835.20%
Debt/Eq0.00
Current Ratio2.45
Quick Ratio2.45
Revenue 5Y-22.47%

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 2.45Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/24/2005
Industry: Biotechnology
P/B i: 2.92
Debt / Equity i: 0.00
Operating Margin: -84500.00%
Net Margin: -83520.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 2.45
Quick Ratio: 2.45
Status: Good

Insider Transactions

Recent executive and insider activity

Weis Holger
Transaction: 08/06/2026
BUY
Change
+4,363
Price
$2.01
Filing
08/11/2026
Type
BUY
Vieser Jaime
Transaction: 07/23/2026
BUY
Change
+8,789
Price
$1.92
Filing
07/27/2026
Type
BUY
Postma Robert W
Transaction: 07/23/2026
BUY
Change
+8,463
Price
$1.92
Filing
07/27/2026
Type
BUY